leisure time -WSS

leisure time

author：explore 2025-09-29 01:36:39 - browse：4

Wraparound views of downtown Boston enrich the employees at the new offices of Foundation Medicine in the Seaport District. — Lane Turner/Globe Staff

Contemporary paintings by artists who have overcome homelessness or disabilities greet visitors in the lobby. Upstairs in the cafeteria, employees order lunches served by local restaurants, including barbecued pulled pork sandwiches from Pennypacker’s. On the top floor, workers can savor a panoramic view of the Seaport District and downtown Boston.

This is the new headquarters of Foundation Medicine, a biotechnology firm that is consolidating its 1,100 Massachusetts employees into a new 16-story brick masonry building at 400 Summer St. Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

About 800 workers have moved into the 630,000-square-foot building, which is kitty-corner from the Boston Convention and Exhibition Center, with the remaining 300 expected to arrive by early next year. No one seems happier about the long-planned consolidation than Dan Malarek, a 17-year veteran of Roche who became Foundation’s chief executive in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Amid AI frenzy, a top HHS official's quest to create safeguards

entertainment

WSS

How to save health care price transparency rules

Change Healthcare can notify patients about the breach, HHS says

First U.S. drug developed to treat liver disease MASH is approved

Intellia reports positive results for its CRISPR

Ionis drug prevents swelling attacks due to hereditary angioedema

Let's speed up science by embracing open access publishing

leisure time

leisure time

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Peter Hotez and the public health issue of online harassment

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Cancer drug shortages should be causing more outrage

As AI in medicine takes off, can 'human in the loop' prevent harm?

At least 13 dead in Texas as scorching temps continue

Why scientists need input from humanists on sensitive research

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

RaDonda Vaught links Vanderbilt hospital issues to patient death

entertainment

RaDonda Vaught links Vanderbilt hospital issues to patient death

Steward Health Care Massachusetts hospitals face fiscal disaster

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Innovation in antibiotics is ailing. 'Brain drain' may kill it

How many hemophilia patients actually want gene therapy?

See how much Covid

leisure time

entertainment

entertainment

knowledge